Michael Rodman

11.4K posts

Michael Rodman banner
Michael Rodman

Michael Rodman

@RodmanM1

Stock Market Trader - No investment advices

Bergabung Temmuz 2020
53 Mengikuti892 Pengikut
Michael Rodman
Michael Rodman@RodmanM1·
$SLP +10% after management lowered fiscal 2026 adjusted diluted EPS guidance to $0.75–$0.85 on a higher expected tax rate, with revenue guidance unchanged at $79M–$82M. stocktitan.net/news/SLP/simul…
English
0
0
0
36
Michael Rodman
Michael Rodman@RodmanM1·
$SAFX +10% gains after New Rise Reno plant conversion stays on schedule with catalyst deliveries end-May/early-June 2026 and commissioning planned early June 2026. stocktitan.net/news/SAFX/xcf-…
English
0
0
0
31
Michael Rodman
Michael Rodman@RodmanM1·
$GLMD +34% gains after announcing brain-penetrating Aramchol with Barcode Nanotech using lipid nanoparticles for subcutaneous BBB delivery and a PoC Ph1b/2 in PD H2 2026 stocktitan.net/news/GLMD/galm…
English
0
0
0
60
Michael Rodman
Michael Rodman@RodmanM1·
$PSTV +22% after appointing Eric J. Daniels as chief development officer effective April 20, 2026 to advance REYOBIQ and its CNS radiopharmaceutical pipeline stocktitan.net/news/PSTV/plus…
English
0
0
2
102
Michael Rodman
Michael Rodman@RodmanM1·
$YMT +44% after Nasdaq notice of noncompliance with $1.00 minimum bid, 180-day cure period until Sept 29, 2026; weighing ADS-to-ordinary share ratio change. stocktitan.net/news/YMT/yimut…
English
0
0
0
104
Michael Rodman
Michael Rodman@RodmanM1·
$OTH +19% gains after announcing a global broker expansion with five-tier recruitment and upgraded NextBoat AI after nearly tripling broker network and capital. stocktitan.net/news/OTH/off-t…
English
0
0
0
47
Michael Rodman
Michael Rodman@RodmanM1·
$ICCC +14% after preliminary Q1 2026 product sales $10.4M, up 28.4%, with domestic $9.7M and Tri-Shield First Defense $7.9M gains; international down 30.2%. stocktitan.net/news/ICCC/immu…
English
0
0
0
51
Michael Rodman
Michael Rodman@RodmanM1·
$PRQR +12% after outlining pipeline progress, saying AX-0810 selected for Phase 2 biliary atresia, AX-0810 target engagement data due this quarter and AX-0811 CTA mid-2026 stocktitan.net/news/PRQR/pro-…
English
0
0
0
103
Michael Rodman
Michael Rodman@RodmanM1·
$EOSE +10% after reporting preliminary Q1 2026 revenue of $56–$57M on record shipments and factory acceptance testing completion for a second battery production line. stocktitan.net/news/EOSE/eos-…
English
0
1
4
274
Michael Rodman
Michael Rodman@RodmanM1·
$ELAB +11% after signing a second long‑term agreement to supply precision CNC components to a Tier 1 aerospace and defense customer for multi‑year programs. stocktitan.net/news/ELAB/aga-…
English
0
0
0
124